Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.
Reissfelder C, Stamova S, Gossmann C, Braun M, Bonertz A, Walliczek U, Grimm M, Rahbari NN, Koch M, Saadati M, Benner A, Büchler MW, Jäger D, Halama N, Khazaie K, Weitz J, Beckhove P.
Reissfelder C, et al. Among authors: saadati m.
J Clin Invest. 2015 Feb;125(2):739-51. doi: 10.1172/JCI74894. Epub 2014 Dec 22.
J Clin Invest. 2015.
PMID: 25562322
Free PMC article.
Clinical Trial.